So as pharma giants release ever more accessible and effective formats, we may see not only more users across the globe, but evolving nutrition needs and tastes as the user profiles change
has served as consultant for Sequana Medical, Cardiol Therapeutics, Genomics plc, Zehna Therapeutics, WhiteSwell, Boston Scientific, CardiaTec Biosciences, Bristol Myers Squibb, Alleviant Medical, Alexion Pharmaceuticals, Salubris Biotherapeutics, BioCardia and has received honorarium from Springer, Belvoir Media Group and American Board of Internal Medicine
There are two types of DMARDS: Conventional nonbiologic types Newer biologic agents While both types target the immune system, biologics target specific immune cell types
Youre interested in a broader antioxidant blend
Some individuals may tolerate the medication better than others